The 7 analysts offering 12-month price forecasts for Coherus BioSciences Inc have a median target of 24.00, with a high estimate of 30.00 and a low estimate of 19.00. The median estimate represents a +32.38% increase from the last price of 18.13.
The current consensus among 7 polled investment analysts is to Buy stock in Coherus BioSciences Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.46
Reporting Date Mar 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.